The Relationship between Circulating Levels of Osteopontin with Carotid Intima-Media Thickness in Children on Regular Hemodialysis — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
The Relationship between Circulating Levels of Osteopontin with Carotid Intima-Media Thickness in Children on Regular Hemodialysis
Pediatric Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
,
Pediatric Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
,
Pediatric Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
,
Clinical Pathology Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
,
Radiology Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
1 Pediatric Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
2 Pediatric Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
3 Pediatric Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
4 Clinical Pathology Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
5 Radiology Department, Faculty of Medicine (for Girls), Al-Azhar University, Cairo, Egypt
Background: Chronic kidney disease (CKD) is associated with cardiovascular morbidity and mortality. Osteopontin (OPN) is a critical factor in developing atherosclerosis and increases the risk for a major adverse cardiovascular event. Aim: To investigate osteopontin serum levels in hemodialysis children and detect the association between the main arteries’ intimal medial thickness (IMT) and peak systolic velocity. Material and Methods: This case-control study included 30 children on regular hemodialysis and 30 children age and sex-matched as controls their age range from 4 to 18 years; we investigated osteopontin serum level in addition to the Doppler ultrasound assessment of intimal medial thickness and peak systolic velocity (PSV) of the main arteries in the same line with the traditional markers of the routine investigations of children on regular hemodialysis. Results: Significantly high osteopontin level in hemodialysis children than the controls was (0.85 ± 0.21 ng/ml) (0.69 ± 0.26 ng/ml), respectively (p = 0.026). A significant increase in the (IMT) of the main arteries, including the carotid and femoral arteries, in the patient’s group than the controls, was (0.51 ± 0.01 mm) (0. 69. ± 0.01 mm) (0.32 ± 0.036 mm) (0.55 ± 0.01), respectively (p = 0.001). There is a strong correlation between (OPN) with the (IMT) of carotid and femoral arteries, a significant positive correlation between (OPN) with urea, creatinine, triglyceride, PTH, ferritin, CRP, and ESR, and a negative correlation with RBCs count and carotid PSV. Conclusion: High osteopontin level is consistent with the increased IMT of the main arteries in hemodialysis children that seem to play a significant role in developing and propagating atherosclerosis in hemodialysis children, evidenced by significant association with inflammatory markers and uremic toxins.
KeywordsChildrenHemodialysisOsteopontin
Kakitapalli, Y., Ampolu, J., Madasu, S.D. and Kumar, M.S. (2020) Detailed Review of Chronic Kidney Disease. Kidney Diseases, 6, 85-91. https://doi.org/10.1159/000504622
Webster, A.C., Nagler, E.V., Morton, R.L. and Masson, P. (2017) Chronic Kidney Disease. Lancet, 389, 1238–1252. https://dio.org/10.1016/S0140-6736(16)32064-5
Alani, H., Tamimi, A. and Tamimi, N. (2014) Cardiovascular Co-Morbidity in Chronic Kidney Disease Current Knowledge and Future Research Needs. World Journal of Nephrology, 3, 156-168. https://dio.org/105527/wjn .v3.i4.156
Kaleta, B. (2019) The Role of Osteopontin in Kidney Diseases. Inflammation Research, 68, 93-102. https://doi.org/10.1007/s00011-018-1200-5
Wolak, T. (2014) Osteopontin—A Multi-Modal Marker and Mediator in Atherosclerotic Vascular Disease. Atherosclerosis, 236, 327-337. https://doi.org/10.1016/j.atherosclerosis.2014.07.004
Scatena, M., Liaw, L. and Giachelli, C.M. (2007) Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascularr Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 2302-2309. https://doi.org/10.1161/ATVBAHA.107.144824
Abdalrhim, A.D., Marroush, T.S., Austin, E.E., Gersh, B.J., Solak, N., Rizvi, S.A., et al. (2016) Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial. PLoS ONE, 11, Article ID: e0156965. https://doi.org/10.1371/journal.pone.0156965
Icer, M.A. and Gezmen-Karadag, M. (2018) The Multiple Functions and Mechanisms of Osteopontin. Clinical Biochemistry, 59, 17-24. https://doi.org/10.1016/j.clinbiochem.2018.07.003
Tousoulis, D., Siasos, G., Maniatis, K., Oikonomou, E., Kioufis, S., Zaromitidou, M., Paraskevopoulos, T., Michalea, S., Kollia, C., Miliou, A., Kokkou, E., Papavassiliou, A.G. and Stefanadis, C. (2013) Serum Osteoprotegerin and Osteopontin Levels Are Associated with Arterial Stiffness and the Presence and Severity of Coronary Artery Disease. International Journal of Cardiology, 167, 1924-1928. https://doi.org/10.1016/j.ijcard.2012.05.001
Wang, K.X. and Denhardt, D.T. (2008) Osteopontin: Role in Immune Regulation and Stress Responses. Cytokine & Growth Factor Reviews, 19, 333-345. https://doi.org/10.1016/j.cytogfr.2008.08.001
Shirakawa, K. and Sano, M. (2021) Osteopontin in Cardiovascular Diseases. Biomolecules, 11, Article No. 1047. https://doi.org/10.3390/biom11071047
Jain, S., Khera, R., Corrales-Medina, V.F., Townsend, R.R. and Chirinos, J.A. (2014) Inflammation and Arterial Stiffness in Humans. Atherosclerosis, 237, 381-390. https://doi.org/10.1016/j.atherosclerosis.2014.09.011
Coll, B., Betriu, A., Martínez-Alonso, M., Amoedo, M.L., Arcidiacono, M.V., Borras, M., Valdivielso, J.M. and Fernández, E. (2011) Large Artery Calcification on Dialysis Patients Is Located in the Intima and Related to Atherosclerosis. Clinical Journal of the American Society of Nephrology, 6, 303-310. https://doi.org/10.2215/CJN.04290510
Dalager, S., Paaske, W.P., Kristensen, I.B., Laurberg, J.M. and Falk, E. (2007) Artery-Related Differences in Atherosclerosis Expression: Implications for Atherogenesis and Dynamics in Intima-Media Thickness. Stroke, 38, 2698-2705. https://doi.org/10.1161/STROKEAHA.107.486480
Gordon, C.E., Balk, E.M., Becker, B.N., Crooks, P.A., Jaber, B.L., Johnson, C.A., et al. (2008) KDOQI US Commentary on the KDIGO Clinical Practice Guideline for the prevention, diagnosis, evaluation, and Treatment of Hepatitis C in CKD. American Journal of Kidney Diseases, 52, 811-825. https://doi.org/10.1053/j.ajkd.2008.08.005
Sivakumar, S. and Devaraj, S.N. (2014) Tertiary Structure Prediction and Identification of Druggable Pocket in the Cancer Biomarker–Osteopontin-C. Journal of Diabetes & Metabolic Disorders, 13, Article No. 13. https://doi.org/10.1186/2251-6581-13-13
Christensen, B., Nielsen, M.S., Haselmann, K.F., Petersen, T.E. and Sorensen, E.S. (2005) Post-Translationally Modified Residues of Native Human Osteopontin Are Located in Clusters: Identification of 36 Phosphorylation and Five O-Glycosylation sites and Their Biological Implications. Biochemical Journal, 390, 285-292. https://doi.org/10.1042/BJ20050341
Jayanthi, K.B., Rajasekaran, C., Madian, N. and Thyagarajah, K. (2017) Analysis on Various Segmentation Techniques–IMT Measurement of Common Carotid Artery. TENCON 2017—2017 IEEE Region 10 Conference, Penang, 5-8 November 2017, 2435-2440. https://doi.org/10.1109/TENCON.2017.8228270
Dhindsa, D.S., Sandesara, P.B., Shapiro, M.D. and Wong, N.D. (2020) The Evolving Understanding and Approach to Residual Cardiovascular Risk Management. Frontiers in Cardiovascular Medicine, 7, Article No. 88. https://doi.org/10.3389/fcvm.2020.00088
Carracedo, J., Alique, M., Vida, C., Bodega, G. and Noemí, C. (2020) Mechanisms of Cardiovascular Disorders in Patients with Chronic Kidney Disease: A Process Related to Accelerated Senescence. Frontiers in Cell and Developmental Biology, 8, Article No. 185. https://doi.org/10.3389/fcell.2020.00185
Lock, S.Z.Y. and Alicia, N. (2019) Osteopontin in Vascular Disease: Friend or Foe? Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 613-622. https://doi.org/10.1161/ATVBAHA.118.311577
Mohamed, A.I., Gadeau, A.P., Hasan, A., Abdulrahman, N. and Mraiche, F. (2019) Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis. Cells, 8, Article No. 1558. https://doi.org/10.3390/cells8121558
Waller, A.H., Sanchez-Ross, M., Kaluski, E. and Klapholz, M. (2010) Osteopontin in Cardiovascular Disease: A Potential Therapeutic Target. Cardiology in Review, 18, 125-131. https://doi.org/10.1097/CRD.0b013e3181cfb646
Murphy-Ullrich, J.E. and Sage, E.H. (2014) Revisiting the Matricellular Concept. Matrix Biology, 37, 1-14. https://doi.org/10.1016/j.matbio.2014.07.005
Druck, A., Patel, D., Bansal, V., Hoppensteadt, D. and Fareed, J. (2019) Osteopontin Levels in Patients with Chronic Kidney Disease Stage 5 on Hemodialysis Directly Correlate with Intact Parathyroid Hormone and Alkaline Phosphatase. Clinical and Applied Thrombosis/Hemostasis, 25, 1-5. https://doi.org/10.1177/1076029619896621
Barreto, D.V., Lenglet, A., Liabeuf, S., Kretschmer, A., Barreto, F.C., Nollet, A., et al. (2011) Prognostic Implication of Plasma Osteopontin Levels in Patients with Chronic Kidney Disease. Nephron Clinical Practice, 117, c363-c372. https://doi.org/10.1159/000321520
Lamort, A.S., Giopanou, I., Psallidas, I. and Stathopoulos, G.T. (2019) Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight. Cells, 8, Article No. 815. https://doi.org/10.3390/cells8080815
Swaminathan, S. and Shah, S.V. (2011) Novel Inflammatory Mechanisms of Accelerated Atherosclerosis in Kidney Disease. Kidney International, 80, 453-463. https://doi.org/10.1038/ki.2011.178
Zoccali, C., Vanholder, R., Massy, Z.A., Ortiz, A., Sarafidis, P., Dekker, F.W., Fliser, D., Fouque, D., Heine, G.H., Jager, K.J., et al. (2017) The systemic nature of CKD. Nature Reviews Nephrology, 13, 344-358. https://doi.org/10.1038/nrneph.2017.52
Podzimkova, J., Palecek, T., Kuchynka, P., Marek, J., Danek, B.A., Jachymova, M., Kalousova, M., Zima, T. and Linhart, A. (2019) Plasma Osteopontin Levels in Patients with Dilated and Hypertrophic Cardiomyopathy. Herz, 44, 347-353. https://doi.org/10.1007/s00059-017-4645-3
Batista, M.C., Welty, F.K., Diffenderfer, M.R., Sarnak, M.J., Schaefer, E.J., Lamon-Fava, S., Asztalos, B.F., Dolnikowski, G.G., Brousseau, M.E. and Marsh, J.B. (2004) Apolipoprotein A-I, B-100, and B-48 Metabolism in Subjects with Chronic Kidney Disease, Obesity, and the Metabolic Syndrome. Metabolism, 53, 1255-1261. https://doi.org/10.1016/j.metabol.2004.05.001
Yuan, Q., Sato, T., Densmore, M., Saito, H., Schüler, C., Erben, R.G., et al. (2012) Deletion of PTH Rescues Skeletal Abnormalities and High Osteopontin Levels in Klotho/Mice. PLoS Genetics, 8, Article ID: e1002726. https://doi.org/10.1371/journal.pgen.1002726
Ono, N., Nakashima, K., Rittling, S.R., Schipani, E., Soma, K., Denhardt, D.T., et al. (2008) Osteopontin Negatively Regulates Parathyroid Hormone Receptor Signaling in Osteoblasts. Journal of Biological Chemistry, 283, 19400-19409. https://doi.org/10.1074/jbc.M800005200
Gepner, A.D., Keevil, J.G., Wyman, R.A., Korcarz, C.E., Aeschlimann, S.E., Busse, K.L., et al. (2006) Use of Carotid Intima-Media Thickness and Vascular Age to Modify Cardiovascular Risk Prediction. Journal of the American Society of Echocardiography, 19, 1170-1174. https://doi.org/10.1016/j.echo.2006.04.009
Stein, J.H., Korcarz, C.E. and Hurst, R.T. (2008) Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine. Journal of the American Society of Echocardiography, 21, 93-111. https://doi.org/10.1016/j.echo.2007.11.011
Chaitanya, V., Harini-Devi, N. and Suchitra, M.M. (2018) Osteopontin, Cardiovascular Risk Factors and Carotid Intima-Media Thickness in Chronic Kidney Disease. Indian Journal of Nephrology, 28, 358-364. https://doi.org/10.4103/ijn.ijn_321_17
Content, J., Durand, M., Sandor, S., Serge, S., Raffort, J., et al. (2021) Plasmatic osteopontin and Vascular Access Dysfunction in Hemodialysis Patients: A Cross-Sectional, Case-Control Study (The OSMOSIS Study). Journal of Nephrology, 1-8. https://doi.org/10.1007/s40620-021-01129-4
Lorenzen, J., Krämer, R., Kliem, V., Bode-Boeger, S.M., Veldink, H., Haller, H., et al. (2010) Circulating Levels of Osteopontin Are Closely Related to Glomerular Filtration Rate and Cardiovascular Risk Markers in Patients with Chronic Kidney Disease. European Journal of Clinical Investigation, 40, 294-300. https://doi.org/10.1111/j.1365-2362.2010.02271.x